Nifuratel

Nifuratel

SCHEMBL28086242

CSCC1CN(/N=C/c2ccc([N+](=O)[O-])o2)C(=O)O1.O=C1OCCN1/N=C/c1ccc([N+](=O)[O-])o1

nearest known ligand 0.70

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 7/20 0.70
ALDH1A1 P00352 7/20 0.70
MAPT P10636 6/20 0.70
TP53 P04637 5/20 0.70
SMN1; SMN2 Q16637 4/20 0.70
CYP1A2 P05177 3/20 0.70
HIF1A Q16665 2/20 0.70
CYP2D6 P10635 1/20 0.70
ALOX15 P16050 1/20 0.70
ATM Q13315 1/20 0.70
KMT2A Q03164 3/20 0.64
USP2 O75604 1/20 0.64
MAPK9 P45984 1/20 0.64
MITF O75030 3/20 0.50
MDM2 Q00987 4/20 0.46
TDP1 Q9NUW8 3/20 0.46
KDM4E B2RXH2 2/20 0.46
CYP3A4 P08684 2/20 0.46
ABCC4 O15439 1/20 0.46
TSHR P16473 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Nifuratel SCHEMBL16675657 0.93 HIF1A (0.68) LMNAALDH1A1MAPTTP53SMN1; SMN2
Nifuratel SCHEMBL1649685 0.93 HIF1A (0.68) LMNAALDH1A1MAPTTP53SMN1; SMN2
Nifuratel SCHEMBL365913 0.93 HIF1A (0.68) LMNAALDH1A1MAPTTP53SMN1; SMN2
Nifuratel SCHEMBL153100 0.93 HIF1A (0.68) LMNAALDH1A1MAPTTP53SMN1; SMN2
Nifuratel SCHEMBL15068213 0.93 HIF1A (0.68) LMNAALDH1A1MAPTTP53SMN1; SMN2
Nifuratel SCHEMBL153098 0.93 HIF1A (0.68) LMNAALDH1A1MAPTTP53SMN1; SMN2
Nifuratel SCHEMBL15375600 0.93 HIF1A (0.68) LMNAALDH1A1MAPTTP53SMN1; SMN2
Nifuratel SCHEMBL28338979 0.92 HIF1A (0.67) LMNAALDH1A1MAPTTP53SMN1; SMN2
Furazolidone SCHEMBL64995 0.84 LMNA (1.00) LMNAALDH1A1MAPTTP53SMN1; SMN2
Furazolidone SCHEMBL11742425 0.84 LMNA (1.00) LMNAALDH1A1MAPTTP53SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103717597-B Heterocyclic compounds as kinase inhibitors 原真股份有限公司 2017-07-04 CN disclosed
CN-103492389-B Pyrazolo [4,3-d] pyrimidine as inhibitors of kinases 原真股份有限公司 2016-09-14 CN disclosed